Philip Wong

1. Clinician Innovator and interventional cardiologist with greater than 25 years of clinical experience and over 3000 cases performed as a primary operator of percutaneous coronary intervention.
Dr Wong has attended to greater than 20,000 outpatient visits over this period.

2. Experienced in pre-clinical research & development of medical devices, including class III/IV implantable devices.

3. Deputy Director, National Heart Center Research Institute Singapore, a newly formed stand alone research entity of the National Heart Center, comprising a 40,000 sq foot state of art basic research facility, Bio-banking and stem cell facility with 30+ research staff, focusing on Induced Pluripotent Stem Cell research and small experimental model imaging in the cardiovascular arena.
This facility incorporates a full suite GMP facility for cell processing on suite to the cardiac labs and operating theaters.
Dr Wong conceptualized and planned the NHRIS facility. Prior to this, Dr Wong led the Research & Development Unit of the NHCS since 2003.

4. A*STAR Program Leader, Cardiovascular Devices.

5. Assoc. Professor, Duke-NUS Graduate Medical School, Singapore.

6. Adjunct Professor, School of materials science and engineering, Nanyang Technological University, Singapore.

7. Founder & Chief Executive Officer/ Chief Technical Officer: Innoheart Pte Ltd; 12,000 sq foot Preclinical Contract Research Organization for evaluation of implantable medical devices.
Dr Wong has been Study PI in over 70 small and large animal studies, including several GLP studies used for regulatory approvals.

8. Founder & Medical Director, WEB Biotechnologies Pte Ltd. WEB produces the Spyder ECG solution, the world’s first Cloud - Based continuous remote ECG monitor. www.web-biotech.com